臨床泌尿器科77巻12号

2023年11月発行

特集 即，実践! 小児の下部尿路機能障害の診療

小児の過活動膀胱の診断と治療

著者： 水野健太郎¹ 西尾英紀¹ 林祐太郎¹

所属機関： ¹名古屋市立大学大学院医学研究科小児泌尿器科学分野

ページ範囲：P.964 - P.972

文献概要

▶ポイント

・小児の過活動膀胱では，尿意切迫感や頻尿を呈する．切迫性尿失禁を伴うことも伴わないこともある．

・それらの症状の原因が下部尿路の器質的疾患の場合があるので，問診や身体診察，排尿観察や画像診断で見逃さないよう心掛ける．

・過活動膀胱と診断したら，一次治療として排尿・排便日誌を用いた行動療法を開始する．それが無効な場合に二次治療を考慮する．

参考文献

1） 三井貴彦 : 小児の非神経因性下部尿路機能障害. In : 日本小児泌尿器科学会 （編） : 小児泌尿器科学. pp262-269, 診断と治療社, 東京, 2021

2） 野口 満 : 小児尿失禁. 臨泌71 : 559-566, 2017

3） Kajiwara M, et al : Nocturnal Enuresis and Overactive Bladder in Children : An Epidemiological Study. Int J Urol 13 : 36-41, 2006

4） Chung JM, et al : Prevalence and Associated Factors of Overactive Bladder in Korean Children 5-13 Years Old : A Nationwide Multicenter Study. Urology 73 : 63-69, 2009

5） Xing D, et al : Prevalence and Risk Factors of Overactive Bladder in Chinese Children : A Population-Based Study. Neurourol Urodyn 39 : 688-694, 2020

6） Veiga ML, et al : Constipation in Children with Isolated Overactive Bladders. J Pediatr Urol 9 : 945-949, 2013

7） Yin L, et al : Clinical Correlation Between Overactive Bladder and Allergy in Children. Front Pediatr 9 : 813161, 2022

8） Yang T-K, et al : Prevalence of Lower Urinary Tract Symptoms in Children with Attention-Deficit/Hyperactivity Disorder : Comparison of Hospital and Population-Based Cohorts of 13,000 Patients. J Clin Med 11 : 6393, 2022

9） Chang S-J, et al : Obese Children at Higher Risk for Having Overactive Bladder Symptoms : A Community-Based Study. Neurourol Urodyn 34 : 123-127, 2015

10） 日本排尿機能学会, 他 （編） : 過活動膀胱診療ガイドライン ［第3版］. リッチヒルメディカル, 東京, 2022

11） Thom M, et al : Management of Lower Urinary Tract Dysfunction : A Stepwise Approach. J Pedatr Urol 8 : 20-24, 2012

12） Allen HA, et al : Initial Trial of Timed Voiding Is Warranted for All Children with Daytime Incontinence. Urology 69 : 962-965, 2007

13） Caldwell PHY, et al : An Alarm Watch for Daytime Urinary Incontinence : A Randomized Controlled Trial. Pediatrics 149 : e2021053863, 2022

14） Li Y, et al : Treatment Experience of 210 Pediatric Patients with Extraordinary Daytime Urinary Frequency : A Prospective Study. Front Pediatr 9 : 713810, 2021

15） Chrzan R, et al : Colonic Washout Enemas for Persistent Constipation in Children with Recurrent Urinary Tract Infections Based on Dysfunctional Voiding. Urology 71 : 607-610, 2008

16） Pekbay Y, et al : The Effects of Pelvic Floor Muscle Therapy on Symptoms, Voiding, and Pelvic Floor Muscle Activity Parameters in Children with Overactive Bladder. Neurourol Urodyn 38 : 1430-1442, 2019

17） Meijer EFJ, et al : Central Inhibition of Refractory Overactive Bladder Complaints, Results of an Inpatient Training Program. J Pedatr Urol 11 : 21, 2015

18） Van Arendonk KJ, et al : Frequency of Wetting Is Predictive of Response to Anticholinergic Treatment in Children with Overactive Bladder. Urology 67 : 1049-1053, 2006

19） Siegmund W, et al : Pharmacokinetics and Pharmacodynamics of Propiverine in Children Aged Between 5 and 10 Years with Symptoms of Overactive Bladder. Clin Pharmacokinet 49 : 335-342, 2010

20） Kim WJ, et al : Efficacy and Safety of Propiverine in Children with Overactive Bladder. Korean J Urol 53 : 275-279, 2012

21） Lapointe É, et al : First North American Experience of Propiverine Use in Children with Overactive Bladder. Can Urol Assoc J 16 : 358-363, 2022

22） Hjälmås K, et al : The Overactive Bladder in Children : A Potential Future Indication for Tolterodine. BJU Int 87 : 569-574, 2001

23） Yucel S, et al : Should We Switch over to Tolterodine in Every Child with Non-Neurogenic Daytime Urinary Incontinence in Whom Oxybutynin Failed? Urology 65 : 369-373, 2005

24） Bolduc S, et al : The Use of Tolterodine in Children After Oxybutynin Failure. BJU Int 91 : 398-401, 2003

25） Nadeau G, et al : Long-Term Use of Solifenacin in Pediatric Patients with Overactive Bladder : Extension of a Prospective Open-Label Study. Can Urol Assoc J 8 : 118-123, 2014

26） Ramsay S, et al : A Randomized, Crossover Trial Comparing the Efficacy and Safety of Fesoterodine and Extended-Release Oxybutynin in Children with Overactive Bladder with 12-Month Extension on Fesoterodine : The FOXY Study. Can Urol Assoc J 14 : 192-198, 2020

27） Gleason JM, et al : Single Center Experience with Oxybutynin Transdermal System （Patch） for Management of Symptoms Related to Non-Neuropathic Overactive Bladder in Children : An Attractive, Well Tolerated Alternative Form of Administration. J Pediatr Urol 10 : 753-757, 2014

28） Kim SC, et al : Efficacy and Tolerability of Mirabegron Compared with Solifenacin for Children with Idiopathic Overactive Bladder : A Preliminary Study. Investig Clin Urol 62 : 317-323, 2021

29） Kitta T, et al : Urodynamic Evaluation of the Efficacy of Vibegron, a New β3-Adrenergic Receptor Agonist, on Lower Urinary Tract Function in Children and Adolescents with Overactive Bladder. J Pediatr Urol 18 : 563-569, 2022

30） Quintiliano F, et al : Transcutaneous Parasacral Electrical Stimulation vs Oxybutynin for the Treatment of Overactive Bladder in Children : A Randomized Clinical Trial. J Urol 193 : 1749-1753, 2015

31） Lambregts AP, et al : Intravesical Botulinum-A Toxin in Children with Refractory Non-Neurogenic Overactive Bladder. J Pediatr Urol 18 : 351.e1-351.e8, 2022